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Clostridioides difficile is the main cause for nosocomial antibiotic associated diarrhea
and has become a major burden for the health care systems of industrial countries.
Its main virulence factors, the small GTPase glycosylating toxins TcdA and TcdB,
are extensively studied. In contrast, the contribution of other factors to development
and progression of C. difficile infection (CDI) are only insufficiently understood. Many
bacterial peptidyl-prolyl-cis/trans-isomerases (PPIases) have been described in the
context of virulence. Among them are the parvulin-type PrsA-like PPIases of Gram-
positive bacteria. On this basis, we identified CD630_35000 as the PrsA2 homolog
in C. difficile and conducted its enzymatic and phenotypic characterization in order to
assess its involvement during C. difficile infection. For this purpose, wild type CdPrsA2
and mutant variants carrying amino acid exchanges mainly in the PPIase domain were
recombinantly produced. Recombinant CdPrsA2 showed PPIase activity toward the
substrate peptide Ala-Xaa-Pro-Phe with a preference for positively charged amino acids
preceding the proline residue. Mutation of conserved residues in its active site pocket
impaired the enzymatic activity. A PrsA2 deficient mutant was generated in the C. difficile
6301erm background using the ClosTron technology. Inactivation of prsA2 resulted in
a reduced germination rate in response to taurocholic acid, and in a slight increase in
resistance to the secondary bile acids LCA and DCA. Interestingly, in the absence of
PrsA2 colonization of mice by C. difficile 630 was significantly reduced. We concluded
that CdPrsA2 is an active PPIase that acts as a virulence modulator by influencing crucial
processes like sporulation, germination and bile acid resistance resulting in attenuated
mice colonization.
Keywords: Clostridioides difficile, PrsA2, peptidyl-prolyl-cis/trans-isomerase, resistance, germination,
colonization
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INTRODUCTION
The Gram-positive obligate anaerobe Clostridioides difficile was
first isolated in 1935 from neonates and identified as part of
their natural intestinal microbiota. In 1978 it was recognized
as the causative agent of enterocolitis and pseudomembraneous
colitis following the introduction of clindamycin, a broad-band
lincosamin antibiotic against Gram-negative anaerobes (Bartlett
et al., 1977; Lusk et al., 1978). In industrialized countries,
C. difficile infection (CDI) has become a major burden in health
care facilities in the last two decades with increasing incidence
numbers in community-associated cases (Rupnik et al., 2009;
Hopkins and Wilson, 2018). The most common severe form of
CDI is pseudomembranous colitis which is a strong inflammation
that goes along with fever, massive tissue destruction of the large
intestine and leucocytosis (Barbut et al., 2007; Rupnik et al.,
2009).
Clostridioides difficile infection is mainly mediated by two
enterotoxins (TcdA and TcdB) that are essential for developing
the disease (Burke and Lamont, 2014). These toxins are taken
up by endocytosis, translocate into the host cell cytosol and
exert their activity by glycosylating and thereby inactivating small
GTPases in human enterocytes. This leads to the collapse of
the actin cytoskeleton dynamics resulting in the distortion of
the gut epithelial barrier and inflammation (Rupnik et al., 2009;
Chandrasekaran and Lacy, 2017). Apart from its enterotoxins,
several other virulence factors that contribute to disease severity
and host colonization have been described for C. difficile and
analyzed to different extents. These include, among others, the
binary toxin CDT (C. difficile toxin) that is present in 5–6%
of historic human isolates, extracellular proteases, surface layer
proteins, several adhesins like a fibronectin binding protein
(Fbp68) or a collagen binding protein (CbpA), flagella and type
IV pili (Geric et al., 2004; Janoir, 2016; Ünal and Steinert, 2016;
Péchiné et al., 2018). Furthermore, the bile acid status of the
infected host was shown to clearly determine the course and
outcome of CDI as patients display a clear shift from antibacterial
to less antibacterial bile acids due to the disturbances of their
indigenous microbiome (Theriot et al., 2016). Besides this, the
arsenal of virulence factors and mechanisms that contribute to
host colonization, disease outbreak and dissemination is still
largely unexplored.
Peptidyl-prolyl-cis/trans-isomerases (PPIases) are ubiquitous
proteins that can be divided into three major classes: the
FK-506 binding proteins (FKBPs), cyclophilins and parvulins
(Schiene-Fischer et al., 2013; Dunyak and Gestwicki, 2016).
Despite their amino acid sequence and structural differences
all classes have in common that they catalyze the rate limiting
isomerization of peptidyl-prolyl bonds during protein folding
(Fischer et al., 1984; Fischer and Bang, 1985; Siekierka et al., 1989;
Rahfeld et al., 1994). By this, they contribute to protein stability,
activity and translocation in bacteria (Behrens-Kneip, 2010; Lyu
and Zhao, 2015). Physiologically, PPIases participate in stress
tolerance, protein homeostasis or secretion. In many instances
PPIases have been shown to contribute to virulence in Gram-
negative and Gram-positive bacteria (Ünal and Steinert, 2014).
The most prominent examples are the macrophage infectivity
potentiator (Mip) of Legionella pneumophila, and PrsA2 of
Listeria monocytogenes (Cahoon and Freitag, 2014; Rasch et al.,
2014).
PrsA2 of L. monocytogenes (LmPrsA2) is a parvulin-type
PPIase that is a lipoprotein and localizes to the cytoplasmic
membrane. Like its homolog PrsA from Bacillus subtilis, it
facilitates folding and efficient secretion of extracellular proteins
(Kontinen et al., 1991; Vitikainen et al., 2004; Cahoon and
Freitag, 2014). LmPrsA2 was first identified in a transposon
mutant study as a factor promoting the virulence related trait
haemolysis (Zemansky et al., 2009). Subsequently, it was shown
to promote the activity or efficient secretion of several other
virulence factors like the metalloprotease Mlp, the phospholipase
PC-LPC, listeriolysin O or the actin-binding and nucleating
protein ActA. Thus, it was influencing the outcome of infection
in cellular and animal models (Alonzo and Freitag, 2010;
Alonzo et al., 2011; Forster et al., 2011). Furthermore, LmPrsA2
homologs have been described in other major Gram-positive
pathogens like Staphylococcus aureus, Streptococcus equi or S. suis
in the context of virulence (Ikolo et al., 2015; Cincarova et al.,
2016; Jiang et al., 2016; Wiemels et al., 2017). Accordingly, in
this study we analyzed the closest homolog of LmPrsA2 in
C. difficile, CD630_35000, in respect to its biochemistry as well
as contribution to physiology and infection.
MATERIALS AND METHODS
Bacterial Strains and Culture
Bacterial strains and plasmids that were used in this study
are listed in Table 1. C. difficile 6301erm and its derivatives
were cultured in BHIS medium (brain-heart infusion broth
(Carl Roth GmbH) supplemented with 5 g/L yeast extract (BD
BactoTM) and 1 g/L L-cysteine (Sigma-Aldrich) under anaerobic
conditions (95% N2/5% H2). If necessary, 5 µg/mL erythromycin
or 15 µg/mL thiamphenicol were added. Escherichia coli and
Bacillus megaterium were cultured in LB medium supplemented
with 100 µg/mL ampicillin, 10 µg/mL tetracycline or 30 µg/ml
chloramphenicol. All antibiotics were purchased from Sigma-
Aldrich. Media were solidified by adding 1.5% (w/v) agar when
needed.
Recombinant Production of CdPrsA2
and Its Single Amino Acid Substitution
Mutants
The prsA2 gene without the first 66 bp encoding for the
N-terminal signal peptide was amplified with the primers
3500_For and 3500_Rev. The PCR product was cloned into
the production vector pSPYocH-hp using the restriction sites
EagI and SpeI yielding a C-terminally His-tagged protein that
is N-terminally coupled to the signal peptide of YocH of
B. subtilis (Stammen et al., 2010). Conserved amino acids,
which were suspected to be involved in PPIase activity were
substituted by alanine. This was done by inverse PCR utilizing
the original production construct as template and primers with
the respective codon changes. The linearized plasmids were gel
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TABLE 1 | Bacterial strains and plasmids used in this study.
Name Features Reference
C. difficile str. 6301erm Erythromycin-sensitive
derivative of strain 630
DSMZ† (DSM 28645),
(Hussain et al., 2005)
C. difficile str. 6301erm1prsA2 cd35000::ClosTron This study
E. coli DH10β Strain for cloning and
plasmid propagation,
F− mcrA 1(mrr-
hsdRMS-mcrBC)
880dlacZ1M15
1lacX74 endA1 recA1
deoR 1(ara, leu)7697
araD139 galU galK
nupG rpsL λ−
Grant et al., 1990
B. megaterium MS941 Strain for recombinant
production, deficient of
the major secreted
protease (1nrpM)
Wittchen and
Meinhardt, 1995
pSPYocH-hp Vector for recombinant
production in
B. megaterium,
PxylA-(−35+
rbs+)-spyocH-mcs-his6,
TcR, AmpR
Stammen et al., 2010
†German Collection of Microorganisms and Cell Cultures.
purified, phosphorylated with T4 polynucleotide kinase (NEB)
and re-ligated with T4 ligase (NEB) according to manufacturer’s
instructions. Plasmids carrying the desired mutations were
selected in E. coli DH10β and verified by sequencing. After
propagation and validation in E. coli DH10β, the protoplasts
of the strain B. megaterium MS941 were transformed using
purified plasmid DNA as described previously (Biedendieck
et al., 2011). For recombinant production, an overnight culture
of the production strain was prepared, and the next morning
refreshed 1:100 in 300 ml LB medium containing 10 µg/mL
tetracycline. The cells were induced at an OD600nm of ∼0.4
by the addition of sterile filtered D-xylose (Carl Roth GmbH)
at a final concentration of 0.5 % (w/v). After 6 h the cells
were removed (3000 g, 15 min, RT), and the supernatant was
sterile filtered as pSPYocH-hp facilitates the secretion of the
recombinantly produced protein into the culture supernatant.
His-tagged PrsA2 and its variants were purified from the
supernatant using Protino R© Ni-TED columns (Macherey-Nagel)
following the manufacturer’s instructions. Protein yield and
purity were analyzed by SDS-page. Correct secondary structure
folding of recombinant proteins was confirmed by circular
dichroism. Primers used in this study are listed in Table 2.
Protease-Free PPIase Assay
Protease-free PPIase assays were performed as previously
described (Zoldák et al., 2009). Briefly, measurements of the
PPIase activity were done in 35 mM HEPES pH 7.8 at 10◦C in a
HP8452 UV/Vis spectrophotometer using the substrate peptide
Suc-Ala-Ala-Pro-Phe-pNA. The time courses were followed at
330 nm after jumping from the peptide stock solution in
0.55 M LiCl/TFE into the final buffer solution. Data analysis
was performed by single exponential non-linear regression.
Measurements were performed at different concentrations of
PrsA2 in triplicate. Determination of kcat/Km was performed
by evaluation of the linear dependency of kenz from the
concentration of PrsA2. Relative errors of the measurements
were calculated using the standard errors of the linear regression.
Substrate specificity was determined using substrate peptides
of the form Abz-Ala-Xaa-Pro-Phe-pNA with Xaa representing
different proteinogenic amino acids. Measurements were done
in a Fluoromax 4 fluorescence spectrophotometer after jumping
from the peptide stock solution in 0.55 M LiCl/TFE into the
final buffer solution. The time courses were followed at 416 nm
after excitation at 316 nm. Relative errors were calculated using
the standard errors of the measurements in triplicate. Data were
analyzed by ANOVA.
Construction of CD630_35000 (prsA2)
Destruction Clones Using ClosTron
A synthetic vector containing the region of prsA2 (CD630_35000)
was designed with the help of the ClosTron website1 using the
Perutka algorithm (Perutka et al., 2004). E. coli CA434 was
transformed with customized vectors for mating with C. difficile
6301erm cells as described previously (Purdy et al., 2002; Heap
et al., 2009, 2010). Mutants were selected on BHIS containing
5 µg/mL erythromycin and confirmed by PCR and sequencing
using gene specific primers.
Determination of Toxin Concentration in
Supernatants
For determining the toxin production, exponentially growing
cultures were adjusted to an OD600 nm of 0.05 in 10 mL of fresh
BHIS and grown at 37◦C under anaerobic conditions. After 48 h,
the culture supernatants of 2 mL of each culture were harvested
(5000 g, 5 min, RT) and sterile filtered using 0.2µm syringe filters.
Toxin concentrations in culture supernatants were determined
using the Clostridium difficile Toxin A OR B ELISA Kit of
tgcBIOMICS (tgc-E002-1) following the manual instructions.
Preparation of Spores
Spores of C. difficile were prepared with slight modifications as
previously described (Sorg and Sonenshein, 2008). Bacteria were
grown over night in BHIS medium, and 100 µL were spread on
BHIS-agar plates, which were incubated for 10 days at 37◦C under
anaerobic conditions. Bacteria and spores were collected using a
sterile loop and suspended in 2 mL ice cold H2Odd. Spores were
separated from vegetative cells by layering this suspension onto
10 ml of sterile 50% (w/v) sucrose solution and centrifugation
(3200 g, 4◦C, 25 min). This step was repeated until a spore purity
of > 95% was reached as assessed microscopically. Spores were
washed five times with H2Odd (5000 g, 4◦C, 10 min), resuspended
in 1 mL of H2Odd, and stored at 4◦C.
Assessment of Sporulation Rates
The spore formation was assessed microscopically as described
previously (Edwards and McBride, 2016). Briefly, 100 µL of an
1http://www.clostron.com/
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TABLE 2 | Primers used in this study.
Name Sequence† Features Reference
PrsA2(wt)_For TATactagtAGTAAAGGAGAAACTGTGGC SpeI This study
PrsA2(wt)_Rev TATcggccgAGATCCACGAGGTACTAAGATTGTGATTTTATTTAT EagI, Thrombin site This study
PrsA2(K188A)_For GCAACAGTAGATGATAATAACAAGCC This study
PrsA2(K188A)_Rev CAATAAAATATGAGAAGCTTCTAC This study
PrsA2(D232A)_For ATATTCACAAGCTACTTCAGCAAG This study
PrsA2(D232A)_Rev TTTTTTGCTACTTTTGCAAAATCCTC This study
PrsA2(L241A)_For GCAGGATTCTTTTCAAGGGGTCAA This study
PrsA2(L241A)_Rev TTTACCACCATCACTTGCTGA This study
PrsA2(M249A)_For GGTCAAGCGGTTGCTGAATTTG This study
PrsA2(M249A)_Rev CCTTGAAAAGAATCCTAATTTACC This study
PrsA2(F253A)_For GCAGAAGATGCTGCTTTTTCTATGAA This study
PrsA2(F253A)_Rev TTCAGCAACCATTTGACCCC This study
PrsA2(T271A)_For GCTCAATATGGATACCACATAATTAAAG This study
PrsA2(T271A)_Rev TTCAACTAAATCAGATACTTCACC This study
PrsA2(Y273A)_For GAAACTCAAGCTGGATACCACAT This study
PrsA2(Y273A)_Rev AACTAAATCAGATACTTCACCCTTT This study
PrsA2(H276A)_For TGGATACGCTATAATTAAAGTGACAG This study
PrsA2(H276A)_Rev TATTGAGTTTCAACTAAATCAGATAC This study
EBS universal primer CGAAATTAGAAACTTGCGTTCAGTAAAC Heap et al., 2007
ErmRAM_F ACGCGTTATATTGATAAAAATAATAGTGGG Heap et al., 2007
ErmRAM_F ACGCGTGCGACTCATAGAATTATTTCCTCCCG Heap et al., 2007
†Highlighted are the bases for the respective alanine exchange, restriction sites are kept in lowercase.
exponentially growing culture were spread out on sporulation
agar plates [63 g Bacto peptone (BD Difco), 3.5 g proteose
peptone (BD Difco), 0.7 g (NH4)2SO4, 1.06 g Tris base, 11.1 g
BHI extract (Roth) and 1.5 g yeast extract (BD Difco) in 1000 mL
H2Odd, autoclave and add 3 ml 10% (w/v) of sterile filtered L-
cysteine (Sigma-Aldrich)]. The plates were incubated at 37◦C
under anaerobic conditions. After 24 h, a loop full of bacteria
were resuspended and fixed for 15 min at room temperature in
100 µL of PBS containing 2% (w/v) paraformaldehyde. Two to
five µL of these suspensions were dropped onto a microscope
slide, pictures of at least three different fields were taken, and the
number of vegetative cells and spores were determined.
Germination Assays
Spore germination in response to the bile acids taurocholate
(TCA) or deoxycholate (DCA) was measured optically as
described previously (Sorg and Sonenshein, 2008, 2009). Briefly,
spores were heat activated at 60◦C for 30 min, adjusted to an
OD600 nm of 0.3–0.5 in 100 µL BHIS containing 5 mM TCA or
1 mM DCA in a 96-well plate, and immediately transferred to a
VarioSkanTM (ThermoFisher) plate reader at room temperature.
Germination of the spores resulted in a decrease in the optical
density, which was recorded every 2 min for 20 min.
Resistance Assays
Overnight cultures were refreshed 1:100 in 10 mL BHIS medium,
cultured to an OD600 nm of 0.8–1.0, and adjusted to 0.1 in
BHIS medium. Bile acids (20 mM stock solution in DMSO)
or antibiotics (5 mM stock solution in DMSO) were serially
diluted 1:1 in a 96-well plate in 100 µL BHIS containing 10%
(v/v) DMSO. Following this, 100 µL of the bacterial solution
were added into each well resulting in a final OD of 0.05 and a
final DMSO concentration of 5% (v/v). Bacteria were grown for
12–16 h at 37◦C under anaerobic conditions, and the final OD
was measured at 600 nm using a VarioSkanTM (ThermoFisher)
plate reader. Medium containing 5% (v/v) DMSO served as
background.
Mouse Colonization Studies
Mice for C. difficile infection were bred at the Helmholtz
Centre for Infection Research (Braunschweig, Germany) under
enhanced specific pathogen free conditions. CHOW AND
IVC. 16–20 weeks old mice (GENDER) were treated with
an intraperitoneal injection of clindamycin (10mg/kg body
weight, Sigma) and 24 h later orally infected with 1000
spores of the indicated strains of C. difficile. Twenty four
hours after infection, fecal samples were collected and mice
were euthanized to obtain cecum and colon content. Samples
were weighed and homogenized, after which aliquots of
homogenized contents were heated for 20 min at 65◦C to
kill vegetative cells. To determine CFU of vegetative cells
and spores, non-heated and heated samples were plated
on CLO agar plates (BioMerieux, 43431), which were for
the heated samples supplemented with taurocholate (0.1%
w/v, Roth) to induce germination of spores. Plates were
incubated for 3 days at 37◦C in an anaerobic environment
(Anaerocult A, Merck). All experiments were performed in strict
accordance with the German Recommendation of the Society
for Laboratory Animal Science (GV-SOLAS) and the European
Health Recommendations of the Federation of Laboratory
Frontiers in Microbiology | www.frontiersin.org 4 December 2018 | Volume 9 | Article 2913
fmicb-09-02913 November 30, 2018 Time: 18:57 # 5
Ünal et al. The PPIase PrsA2 as Virulence Modulator in C. difficile
Animal Science Associations. The animal protocol was approved
by the “Niedersächsisches Landesamt für Verbraucherschutz und
Lebensmittelsicherheit”: (33.9-42502-04-14/1415).
RESULTS
C. difficile Encodes Proteins With Strong
Amino Acid Sequence Similarity to
PPIases
We screened the reference genome of C. difficile str. 630
(NC_009089.1) for the presence of genes encoding parvulin
homologs and identified four putative candidates (Table 3). Of
those four, two contained putative secretion signals (SP) that can
be recognized by the signal peptidase II as predicted by LipoP
1.0 (Juncker et al., 2003; Rahman et al., 2008). This is similar
to L. monocytogenes where, in contrast to the model organism
B. subtilis, two membrane localized PrsA-homologs are present
(Cahoon et al., 2016). In order to determine the closest homolog
of the virulence associated PrsA2 of L. monocytogenes (LmPrsA2),
we performed an amino acid sequence alignment with Clustal
Omega (Sievers et al., 2011). For this, we used the sequences
of LmPrsA2 and the four putative parvulin-type PPIases from
C. difficile, CD630_13570, CD630_15570, CD630_22630 as
well as CD630_35000. Out of those, CD630_35000 had with
32.96% identity the highest similarity on amino acid level
to LmPrsA2 and separated in this respect clearly from the
remaining parvulins of C. difficile (Figure 1A). Further amino
acid sequence comparisons of CdPrsA2 (CD630_35000) with
LmPrsA1, LmPrsA2, BsPrsA and the human parvulin Pin1
(HsPin1) identified highly conserved amino acids, mostly in
the well-defined PPIase domain (Figure 1B). This amino acid
sequence alignment shows the close relatedness between BsPrsA,
LmPrsA1 and LmPrsA2. Interestingly, CdPrsA2 contained a
stretch of 21 amino acids (K188-K208) that was absent in
the other bacterial parvulins. Interestingly, HsPin1 contains a
stretch of amino acids which is approximately of the same
length. Overlaying an available structural model of the PPIase
domain of BsPrsA with HsPin1 showed that this stretch
corresponded to a flexible loop in HsPin1 that is absent in
BsPrsA (Figure 1C). The 996 bp long CdPrsA2 gene is localized
on the chromosome between the gene for RNA polymerase
removal factor Mfd upstream and the gene encoding the
TABLE 3 | Putative parvulin-type PPIases of C. difficile.
Locus tag‡
Accession number† 630 6301erm R20291 SP §
Q18BM5 13570 01513 1199 –
Q18C77 15570 01726 1406 +
Q185D5 22630 02497 2162 –
Q180Z8 35000 03813 3337 +
†Uniprot IDs, ‡ in the reference genomes NC_009089.1 (str. 630), CP016318.1.
(str. 6301erm) and FN545816.1 (str. R20291), §signal peptide as determined by
SignalP 4.1.
highly conserved forespore-specific transcription factor SpoVT
downstream (Figure 1D) (Asen et al., 2009; Willing et al.,
2015).
CdPrsA2 Is an Active Parvulin
For evaluating whether CdPrsA2 is an active parvulin, we
recombinantly produced a C-terminally His-tagged CdPrsA2
lacking its putative signal peptide and lipid modification as well
as its single alanine-exchange mutant variants in B. megaterium
MS941 and performed in vitro protease-free PPIase assays
using the substrate peptide Abz-Ala-Ala-Pro-Phe-pNA. Wild
type CdPrsA2 was active in the protease-free PPIase assay with
a catalytic efficiency (kcat/Km) of 6.78 ± 0.41 × 104 M−1s−1
(Figure 2A and Table 4). In order to functionally identify
amino acid residues involved in the observed enzymatic activity,
conserved residues of the PPIase domain were deduced from the
outlined amino acid sequence comparisons (D232, L241, M249,
F253, T271, Y273, H276). Additionally, K188 was selected due to
its possible functional homology to K63 in HsPin1 (Zhou et al.,
2000) (Figure 1B). Among the eight amino acid replacements,
Y273A, T271A, and F253A were the most deleterious ones
with catalytic efficiencies dropping to 1.06 ± 0.24 × 103
M−1s−1, 1.06 ± 0.10 × 103 M−1s−1, 1.61 ± 0.23 × 103
M−1s−1, respectively, and resulting in an activity loss of about
98% compared to the wild type protein. This was followed
L241A with 92% reduced activity and a catalytic efficiency of
5.02 ± 0.50 × 103 M−1s−1 (Figure 2B). Two substitution
mutants, namely M249A and H276A, revealed activity losses
of about 20 and 70%, respectively. Also, exchanging the non-
canonical K188 by alanine caused a loss in activity by about
45% to a kcat/Km value of 3.65 02 ± 0.40 × 104 M−1s−1. In
contrast, substituting D232 by an alanine caused an opposite
effect and increased the catalytic efficiency of the enzyme 2.6-fold
to 1.80± 0.05× 105 M−1s−1 (Figure 2B).
Next, we analyzed the substrate preference of CdPrsA2 by
using the wild type protein with variants of the substrate
peptide Abz-Ala-Xaa-Pro-Phe-pNA containing different amino
acid residues Xaa preceding the proline residue (Table 5). The
catalytic efficiency of CdPrsA2 for a substrate peptide with
leucine instead of alanine was with 8.5 × 105 M−1s−1 about
2.6-fold increased. We concluded a clear preference of CdPrsA2
toward positively charged amino acids preceding proline, as the
peptides containing arginine or lysine were isomerized 2.3-fold
and 1.76-fold faster resulting in kcat/Km values of 7.58 × 105
M−1s−1 and 5.67 × 105 M−1s−1, respectively. In agreement
with this, the catalytic efficiency for a substrate peptide with
the negatively charged glutamate was reduced by around 90%
to 3.2 × 104 M−1s−1. Peptides containing isoleucine or valine
were less suitable substrates as their kcat/Km values were reduced
by 87 and 92% to 4.26 × 104 M−1s−1 and 2.7 × 104 M−1s−1,
respectively (Figure 2C).
CdPrsA2 Is Involved in Stress Responses
Next, we analyzed its physiological role by disrupting the
CdPrsA2 gene using the ClosTron technology. The ClosTron
element was found inserted between bps 262 and 263
(Figure 1D). The mutant revealed no obvious growth defect in
Frontiers in Microbiology | www.frontiersin.org 5 December 2018 | Volume 9 | Article 2913
fmicb-09-02913 November 30, 2018 Time: 18:57 # 6
Ünal et al. The PPIase PrsA2 as Virulence Modulator in C. difficile
FIGURE 1 | CD630_35000 is the closest homolog of PrsA2 of L. monocytogenes in C. difficile with unique features. (A) Similarity analysis of all putative parvulins of
C. difficile with the virulence associated parvulin LmPrsA2 of L. monocytogenes shows that CD630_35000 (CdPrsA2) displays the highest similarity to LmPrsA2.
(B) Alignment of amino acid sequences of CdPrsA2 (Q180Z8), LmPrsA1 (Q71ZM6) and LmPrsA2 (Q71XE6) of L. monocytogenes, BsPrsA (P24327) of B. subtilis
and HsPin1 (Q13526) of humans reveals highly conserved amino acids, especially in the PPIase domain (underlined). The alignment was performed using the
T-Coffee webserver and visualized by Jalview 2.10.3b1. Amino acids that are conserved to 100% are highlighted by color coding according to Taylor (Taylor, 1986;
Notredame et al., 2000; Waterhouse et al., 2009). Amino acids that have been mutated in CdPrsA2 for enzymatic studies are marked by an asterisk. A variable loop
that aligns with the human HsPin1 and is absent in all other bacterial PrsA proteins is highlighted in red. (C) Structural alignment of HsPin1 (pdb:1NMV) and BsPrsA
(pdb: 4WO7) reveals a loop (highlighted in red) in the human parvulin that has no homology in BsPrsA but aligns with CdPrsA2 (see also B). Shown in red is the side
chain of the catalytically important amino acids K63 in HsPin1 that corresponds to K188 in CdPrsA2. (D) Shown is the genetic localization of the 996 base pairs long
ORF of CD630_35000 (CdPrsA2) in the genome of C. difficile strain 6301erm with the integration site of the ClosTron construct between bases 262 and 263.
Shown are also the downstream adjacent genes spoVB and spoVT as well as the upstream adjacent gene mfd.
rich BHIS-medium (Figure 3A). Similarly, the spore forming
capacity and the toxin titres of stationary liquid cultures were
comparable between the prsA2::ClosTron mutant and its isogenic
wild type (Figures 3B,C). PPIases are typically involved in
various stress responses in bacteria. Consequently, we analyzed
the contribution of CdPrsA2 to different stress responses of
C. difficile. As stressors we used the two most common
therapeutic antibiotics, vancomycin and metronidazole, and
the two main secondary bile acids of the healthy intestine,
lithocholic acid (LCA) and deoxycholic acid (DCA) that inhibit
vegetative cell growth. When treated with vancomycin, no
significant difference between the wild type strain and its
isogenic prsA2::ClosTron mutant was detected (Figure 4A).
In contrast, a significant reduction in resistance from 16 to
8 µM metronidazole was observed for the mutant strain
(Figure 4B). The mutant strain was found less susceptible
toward bile acids, with 31 µM of LCA (Figure 4C) and
125 µM of DCA (Figure 4D), concentrations at which the
vegetative growth of the wild type strain was significantly
impaired.
Response to Germination Inducing Bile
Salts Is Impaired in Spores Lacking
CdPrsA2
The germination of spores is the crucial step for colonization and
developing acute CDI. Accordingly, we evaluated the response
TABLE 4 | Relative catalytic activity of alanine substitution mutants of CdPrsA2.
PrsA2 kcat/Km (M−1 s−1)
Wild type (6.78 ± 0.41) × 104
D232A (1.80 ± 0.05) × 105
M249A (5.49 ± 0.16) × 104
Y273A (1.06 ± 0.24) × 103
H276A (2.61 ± 0.06) × 104
K188A (3.65 ± 0.40) × 104
T271A (1.06 ± 0.10) × 103
F253A (1.61 ± 0.23) × 103
L241A (5.02 ± 0.50) × 103
of spores derived from the wild type strain and isogenic
prsA2::ClosTron mutant. For this purpose, we used the bile acid
DCA at a concentration of 1 mM and sodium taurocholate (TCA)
with 5 mM and monitored the initial stages of germination by
measuring the drop in OD at 600 nm every 2 min for 20 min after
the addition of the respective bile acid. The change in relative OD
indicated a significant response of the wild type strain to both bile
acids. The relative OD decreased by about 20% during treatment
with 1 mM DCA (Figure 5A) and by about 25% with 5 mM
TCA (Figure 5B) until it reached a plateau at 20 min. In contrast,
spores of the prsA2 deficient mutant did not respond to both bile
acids in the same time frame and showed less than 5% loss in OD
(Figures 5A,B).
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FIGURE 2 | PPIase activity profile of CdPrsA2. (A) Determination of the
catalytic efficiency of wtPrsA2 (kcat/Km 6.78 × 104 M−1 s−1) by evaluation of
the linear dependency of kenz from the concentration of the protein. The
cis/trans isomerization of the PPIase substrate Suc-Ala-Ala-Pro-Phe-pNA was
measured by the protease-free PPIase activity assay. The time courses were
followed using a HP 8452 diode array spectrophotometer at 330 nm after
jumping from the peptide stock solution in LiCl/TFE into the final buffer
solution at 10◦C. Measurements were done in 35 mM HEPES pH 7.8. Each
data point represents the mean of three independent measurements. (B)
Substitution of selected conserved amino acids in the PPIase domain by
alanine revealed that especially the amino acids in the catalytic core Y273,
T271, F253 and L241 are involved in the PPIase activity. Substitution of Y273
and T271 reduced the catalytic efficiency to 1.5% of the wild type protein,
whereas the alanine substitutions of F253 and L241 yielded catalytic
efficiencies of 2.3 and 7.4%, respectively. Moderate changes were observed
when M249 or H276 were replaced by alanine, which decreased catalytic
efficiencies to 80.5 and 38.5%, respectively. Replacement of the
non-canonical K188 by alanine yielded a variant with only 53.8% residual
efficiency. Substituting D232 by alanine resulted in 264% increased PPIase
(Continued)
FIGURE 2 | Continued
activity compared to wild type protein. (C) Relative PPIase activities of
CdPrsA2 for substrates with different amino acids N-terminal to proline
compared to its activity towards Abz-Ala-Ala-Pro-Phe-pNA. Determination of
kcat/Km was performed by evaluation of the linear dependency of kenz from
the concentration of CdPrsA2. Catalytic efficiencies were increased to 264,
236, or 176% for substrates with leucine or the positively charged amino
acids arginine or lysine preceding proline, respectively. In contrast, the
catalytic efficiency dropped to 9.9% or to 8.4%, when substrate peptides
containing glutamate or valine were used, respectively. Data are means and
SEM of three independent measurements. Statistical significance was
determined by one-way analysis of variance (ANOVA), (∗p ≤ 0.05).
CdPrsA2 Contributes to Colonization of
Mice
Having seen the differential effects in C. difficile regarding bile
acid responses, we evaluated the prsA2 deficient mutant in a
mouse colonization model. For this purpose, 4 months old mice
that had been treated with clindamycin were infected orally
with 1000 spores of C. difficile str. 6301erm or its isogenic
prsA2::ClosTron mutant. The mice were sacrificed 24 h after
infection, and the cecum and colon contents as well as the
feces were collected. The colonization of the mice was assessed
by determining the colony forming units (cfu) of each strain
on selective agar. Mice infected with wild type spores yielded
a higher bacterial burden in their cecum and colon compared
to the mutant strain (Figures 6A,B). In the cecum, 106 cfu/g
of vegetative cells were recovered. This was about 10-fold and
by this significantly higher (p ≤ 0.01) than in mice infected
with the PrsA2-deficient mutant (Figure 6A). This difference
was even higher in the colon, where 105 cfu/g of vegetative
cells of wild type compared to about 5 × 103 cfu/g (p ≤ 0.001)
of vegetative cells of the mutant were recovered (Figure 6B).
In contrast, no difference in the count of vegetative cells
was observed between the strains in the feces, where about
3.5 × 103 cfu/g were recovered for both strains (Figure 6C).
The spore numbers of the wild type were with 4.5 × 104 vs.
3.2 × 103 cfu/g in the colon and 5.2 × 105 vs. 104 cfu/g in
feces significantly higher for the wild type (Figures 6B,C). No
significant differences in the spore counts were measured in the
cecum (Figure 6A).
DISCUSSION
The multi-resistant pathogen C. difficile is a steadily growing
problem for the health care systems of industrialized countries
as its spread goes along with the broad use of antibiotics
in communities with a demographic change toward a care-
intensive population. While the acute disease is mainly caused
by the enterotoxic activity of two large clostridial toxins,
TcdA and TcdB, there are many additional factors that
influence colonization, persistence and recurrence. However,
the systematic investigation of non-toxin virulence factors lags
considerably behind that of TcdA and TcdB. Accordingly, in
this study we aimed at narrowing this gap by characterizing the
PrsA2-homolog, a parvulin-type PPIase, of C. difficile.
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FIGURE 3 | Deletion of CdPrsA2 does not affect growth, sporulation or toxin production. (A) Growth in BHIS medium was measured over 24 h every 90 min for the
first 14 h. Shown is the mean and standard deviation of two separate experiments performed in duplicates. (B) Sporulation of 6301erm (wild type) and its isogenic
1prsA2::ClosTron mutant (1prsA2) was induced on sporulation plates for 24 h, and monitored microscopically. The number of spores was put in relation to the
vegetative cells in order to assess the sporulation rate in percentage. Shown are the results of three independent experiments. (C) Toxin concentrations in 48 h old
culture supernatants were measured by ELISA and revealed no substantial differences between 6301erm (wild type) and its isogenic 1prsA2::ClosTron mutant
(1prsA2).
PrsA of B. subtilis is important for the secretion of extracellular
proteins (Kontinen et al., 1991; Jacobs et al., 1993; Yan and
Wu, 2017; Ma et al., 2018). Homologs of PrsA in pathogenic
bacteria very often contribute to pathogenicity by the secretion
of extracellular virulence factors (Ünal and Steinert, 2014;
Jiang et al., 2016; Wiemels et al., 2017; Lin et al., 2018).
The most prominent example of these proteins is LmPrsA2
of L. monocytogenes, which has in addition to many other
pathogens like S. aureus or Streptococci two homologs of
this protein (Cahoon and Freitag, 2014). For our study, we
identified all four putative parvulin-like PPIases of C. difficile
and determined by sequence homology that CD630_35000 is
the closest homolog to LmPrsA2. Additionally, CD630_35000
was confirmed as a lipoprotein in an experimental lipoproteomic
approach (Charlton et al., 2015). Further analysis revealed that
CdPrsA2, although closely related to the PrsA2 proteins of
B. subtilis and L. monocytogenes, may have structural differences
that might have functional consequences. The most interesting in
this respect is certainly an additional 21 amino acid long stretch
starting with K188 (Figure 1C). This stretch exhibits a certain
similarity to a loop region in the human parvulin Pin1 that
is involved in enzymatic activity and substrate discrimination
(Zhou et al., 2000). In the light of these preliminary findings
we decided to perform a systematic substitution analysis
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FIGURE 4 | CdPrsA2 confers metronidazole resistance and renders the bacteria sensitive to secondary bile acids. (A) Vancomycin is equally effective against
vegetative C. difficile 6301erm (wild type) and its isogenic 1prsA2::ClosTron mutant with a minimal inhibitory concentration (MIC) of ≥ 1 µM. (B) In case of
metronidazole the 1prsA2::ClosTron mutant showed increased sensitivity as the MIC dropped from ≥ 8 µM to ≥4 µM. In the absence of PrsA2 C. difficile can
tolerate higher concentrations of the secondary acids (C) litocholic acid (LCA) and (D) deoxycholic acid (DCA) as the MICs for the substances increase
from ≥ 16 µM to ≥31 µM, and from ≥63 µM to ≥125 µM, respectively. Shown are the mean and standard deviation of three independent experiments performed in
duplicates. Significance was calculated using unpaired two-sided Student’s t-test (∗p ≤ 0.05, ∗∗p ≤ 0.01).
TABLE 5 | Substrate specificity of wild type CdPrsA2 protein.
Xaaa kcat/Km (M−1 s−1)
Ala (3.21 ± 0.27) × 105
Leu (8.50 ± 0.67) × 105
Ile (4.26 ± 0.51) × 104
Val (2.70 ± 0.23) × 104
Lys (5.67 ± 1.30) × 105
Arg (7.58 ± 1.85) × 105
Glu (3.20 ± 0.26) × 104
Gln (3.96 ± 0.08) × 105
Met (5.77 ± 1.22) × 105
Phe (3.33 ± 0.58) × 105
Tyr (1.63 ± 0.32) × 105
Trp (2.58 ± 0.40) × 105
aAmino acids used to replace the position preceding proline in the substrate
peptide Abz-Ala-Xaa-Pro-Phe-pNA.
with conserved amino acids. Here, we demonstrated that the
recombinant protein was indeed an active parvulin and that
the most conserved amino acids within the PPIase domain,
namely L241, F253 and Y273 are crucial for its enzymatic activity
(Figure 2B). Substituting D232 with alanine resulted in increased
PPIase activity suggesting that this residue also contributes to
substrate selectivity. Interestingly, K188, which corresponds to
K63 in human Pin1 but is not present in other PrsA2 proteins
analyzed, also influences the activity of CdPrsA2. In Pin1, this
positively charged residue together with R68 and R69 form a basic
cluster which recognizes phospho-serine or phospho-threonine
residues and facilitates its participation in mammalian signaling
cascades (Zhou et al., 2000). With this substrate specificity Pin1
takes a special place among eukaryotic PPIases, whereas there are
no reports for a selectivity toward phosphorylated amino acids
in bacterial PPIases. Thus, we elucidated the substrate specificity
of recombinant wild type CdPrsA2. Interestingly, we observed
a clear preference of CdPrsA2 toward substrates containing
positively charged amino acids preceding proline, which is similar
to the substrate specificity of the second human parvulin Par14
(Uchida et al., 1999). Probably, K188 in CdPrsA2 does not
contribute to substrate selectivity as K63 in Pin1. In contrast
to Pin1, the 21 amino acid stretch of CdPrsA2 contains three
aspartate residues and thus, might determine the preference for
positively charged substrates together with D232. Also, it should
be noted that CdPrsA2 might have a relatively broad substrate
spectrum as the cis/trans isomerization of peptides with leucine,
glutamine, methionine and phenylalanine preceding the proline
was also accelerated at high rates.
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FIGURE 5 | CdPrsA2 influences germination efficiency of C. difficile spores.
Germination of C. difficile 6301erm (wild type) and its isogenic
1prsA2::ClosTron mutant (1prsA2) in the presence of (A) 1 mM deoxycholic
acid (DCA) or (B) 5 mM taurocholic acid (TCA) was assessed in 96-wells by
measuring the change in optical density of the spore suspension at OD600 nm
over 20 min. Plotted is the change in optical density relative to the starting OD
at t0. Shown are the means and SEM of three measurements performed with
spores of two different preparations. Statistical significance was calculated
using Student’s t-test (∗p ≤ 0.05).
In order to analyze the role of CdPrsA2 in C. difficile
physiology, we generated a gene disruption mutant using the
ClosTron technology. The mutant showed no major differences
regarding growth in BHIS, sporulation on agar or toxin titres.
Furthermore, the prsA2::ClosTron mutant and the wild type
were comparably susceptible toward the cell wall targeting
antibiotic vancomycin. In contrast, an increased susceptibility
toward metronidazole, the second common first line antibiotic
against CDI, was observed in the mutant (Figure 4B). This
antibiotic that is administered against anaerobic pathogens
exerts its activity mainly by causing DNA damage (Dhand and
Snydman, 2009). In recent years, the resistance toward this
considerably cheap antibiotic has constantly been rising among
C. difficile isolates. However, the exact mechanisms conferring
metronidazole resistance in C. difficile are not known. Suggested
are increased activity of nitroreductases, iron uptake and DNA
repair mechanisms (Peng et al., 2017). Among these, CdPrsA2
might influence the iron uptake by modulating the concentration
or activity of membrane associated transporters.
Interestingly, in the absence of PrsA2 the resistance of
C. difficile toward the secondary bile acids LCA and DCA
significantly increased. The antibacterial effect of bile acids is
a well-known phenomenon, as the probability and severity of
acute CDI clearly correlate with the bile acid status of the host
(Sung et al., 1993; Buffie et al., 2015). Nevertheless, the exact
mode of action for the antibiotic activity of bile acids is still
speculative. Considering their mainly hydrophobic nature, the
disturbance of bacterial membranes is the most likely mode
of action followed by interfering with the stability of cellular
macromolecules like DNA, RNA or proteins. Most common
bile tolerance or resistance mechanisms in bacteria include
the modification of the outer membrane in Gram-negatives
as well as the upregulation of transporters, eﬄux pumps or
bile acid modifying enzymes in Gram-negative and Gram-
positives (Begley et al., 2005). Many bacteria of the commensal
microbiome, like C. scindens, are known to convert primary bile
acids of the host to secondary bile acids that exert antibacterial
activity on vegetative C. difficile and inhibit spore germination
which contributes to the naïve colonization barrier in healthy
individuals (Sorg and Sonenshein, 2009; Studer et al., 2016;
Weingarden et al., 2016). In addition, especially the primary bile
acid TCA and the secondary bile acid DCA induce germination
of the spores, which is the key event leading to acute disease (Sorg
and Sonenshein, 2008). How C. difficile might directly cope with
bile acid stress is currently not known. Only recently a bile acid
modifying 7α-hydroxysteroid dehydrogenase was biochemically
FIGURE 6 | CdPrsA2 is important for colonization of mice. Twenty to twenty four weeks old mice old clindamycin treated mice were infected with 1000 spores of
either C. difficile 6301erm and its isogenic 1prsA2::ClosTron mutant (1prsA2) per mouse, sacrificed after 24 h, and (A) cecum, (B) colon contents as well as (C)
feces were collected. The number of vegetative cells and spores in each compartment were determined by plating out serial dilutions on CLO plates (bioMérieux)
with or without 0.1% (w/v) TCA. Samples were heated prior to plating out for the determination of spore numbers. Significantly higher cfu of vegetative cells could be
isolated from cecum and colon of mice infected with the wild type as compared with the 1prsA2 mutant. Furthermore, significantly less spores of the mutant were
recovered in the colon and feces samples. Significance was calculated using unpaired two-sided Student’s t-test (∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001).
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characterized, while its contribution to bile acid dependent
physiology of the bacterium remains unsolved (Bakonyi and
Hummel, 2017). Considering the increase in resistance in the
CdPrsA2-deficient mutant and a probable role of the protein in
the composition of the outer layer of the bacterium, it is very
likely that the interaction of LCA or DCA with the bacteria
is hampered either by the reduced presence of a yet unknown
receptor or a membrane modifying enzyme.
Most interestingly, PrsA2 deficiency resulted in a substantial
loss in germination in response to the bile acids TCA and
DCA (Figure 5). The germination is the initial step in the
transformation to toxin producing vegetative cells and as such
the development of acute disease. Germination in C. difficile
differs from other clostridia and the model organism B. subtilis
in regard to the regulatory cascades that are activated upon the
detection of bile acids and amino acids as germination signals. Its
main actors are the bile acid receptor CspC and the downstream
proteases CspA, CspB, and SleC (Burns et al., 2010; Francis
et al., 2013; Paredes-Sabja et al., 2014). How PrsA2 influences
the germination of C. difficile still needs to be analyzed in detail,
but the reduced response toward bile acids could also explain
the reduced capability of the mutant to colonize mice. In orally
infected mice the number of vegetative cells 24 h p.i. were
significantly reduced in the cecum and colon. The same was
true for the number of spores in the colon and feces, whereas
interestingly the spore numbers in the cecum were comparable.
This might indicate that the wild type due to a normal response
toward bile acids can transform much earlier and more efficiently
into vegetative cells and start the colonization. This early onset
of infection most probably leads also to higher spore burden
in the distal part of the gastrointestinal tract and finally in the
feces. CdPrsA2, like all the other PPIases of C. difficile, has
consistently been found in proteomic studies including the spore
(Lawley et al., 2009; Charlton et al., 2015). However, CdPrsA2 was
shown to be the only PPIase that was significantly upregulated
throughout the first 30 h of infection in mice indicating that it
actively participates in the infection process (Fletcher et al., 2018).
CONCLUSION
We suggest that the extracellular PPIase PrsA2 of C. difficile is
enzymatically active with a preference for substrates containing
positively charged amino acids. Furthermore, it acts as a virulence
modulator by influencing important processes including
germination and bile acid resistance that all together contribute
to the colonization efficiency of the bacteria. By this, it is part of
the virulence repertoire of C. difficile whose pathogenic potential
reaches beyond the toxic activity of TcdA and TcdB.
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